Document:

EX-10.1

 Exhibit 10.1 

Execution Version 

REGISTRATION RIGHTS AGREEMENT 

BY AND AMONG 
 MCDERMOTT
INTERNATIONAL, INC. 
 AND 

THE PURCHASERS PARTY HERETO 

 Table of Contents 

 

							
	 	  	 	  	Page	 
	 ARTICLE I DEFINITIONS
	  	 	1	 
			
	 Section 1.01
	  	Definitions	  	 	1	 
	 Section 1.02
	  	Registrable Securities	  	 	4	 
	 Section 1.03
	  	Rules of Construction	  	 	5	 
		
	 ARTICLE II REGISTRATION RIGHTS
	  	 	5	 
			
	 Section 2.01
	  	Shelf Registration	  	 	5	 
	 Section 2.02
	  	Delay Rights	  	 	7	 
	 Section 2.03
	  	Underwritten Offering	  	 	8	 
	 Section 2.04
	  	Sale Procedures	  	 	9	 
	 Section 2.05
	  	Cooperation by Holders	  	 	13	 
	 Section 2.06
	  	Restrictions on Sales	  	 	13	 
	 Section 2.07
	  	Expenses	  	 	13	 
	 Section 2.08
	  	Indemnification	  	 	13	 
	 Section 2.09
	  	Rule 144 Reporting	  	 	15	 
	 Section 2.10
	  	Transfer or Assignment of Registration Rights	  	 	16	 
	 Section 2.11
	  	Liquidated Damages Payments Under Certain Circumstances	  	 	16	 
	 Section 2.12
	  	Limitations on Subsequent Registration Rights	  	 	17	 
		
	 ARTICLE III MISCELLANEOUS
	  	 	17	 
			
	 Section 3.01
	  	Termination and Effect of Termination	  	 	17	 
	 Section 3.02
	  	Notices and Communications	  	 	17	 
	 Section 3.03
	  	Entire Agreement	  	 	18	 
	 Section 3.04
	  	Amendments and Waivers	  	 	19	 
	 Section 3.05
	  	Binding Effect; Benefits of This Agreement	  	 	19	 
	 Section 3.06
	  	Assignment of Holders’ Rights	  	 	19	 
	 Section 3.07
	  	Recapitalization, Exchanges, Etc.	  	 	19	 
	 Section 3.08
	  	Specific Performance	  	 	19	 
	 Section 3.09
	  	Governing Law; Jurisdiction and Venue; Waiver of Jury Trial	  	 	20	 
	 Section 3.10
	  	Severability	  	 	20	 
	 Section 3.11
	  	Counterparts	  	 	21	 
	 Section 3.12
	  	Table of Contents and Headings	  	 	21	 
	 Section 3.13
	  	No Adverse Interpretation of Other Agreements	  	 	21	 
	 Section 3.14
	  	No Presumption	  	 	21	 
	 Section 3.15
	  	Obligations Limited to Parties to This Agreement	  	 	21	 

  
 i 

 This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered
into as of November 29, 2018, by and among McDermott International, Inc., a company organized under the laws of the Republic of Panama (the “Company”), and the purchasers specified on the signature pages hereof (the
“Purchasers”). 
 WHEREAS, this Agreement is entered into in connection with the closing of the issuance of the Preferred
Shares (as defined below) and the Warrants (as defined below) to the Purchasers pursuant to the Securities Purchase Agreement, dated October 30, 2018 (the “Purchase Agreement”), by and among the Company and the Purchasers; and

 WHEREAS, the Company has agreed to provide the registration and other rights set forth in this Agreement for the benefit of the
Purchasers pursuant to the Purchase Agreement; and 
 WHEREAS, it is a condition to the obligations of the Purchasers and the Company under
the Purchase Agreement that this Agreement be executed and delivered. 
 NOW THEREFORE, in consideration of the mutual covenants and
agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party hereto, the parties hereby agree as follows: 

ARTICLE I 
 DEFINITIONS

 Section 1.01 Definitions. Capitalized terms used herein without definition shall have the meanings given to them in the
Purchase Agreement. The terms set forth below are used herein as so defined: 
 “Affiliate” has the meaning assigned to such
term, as of the date hereof, in Rule 405 under the Securities Act. 
 “Agreement” has the meaning specified therefor in the
introductory paragraph to this Agreement. 
 “Beneficially Own” has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5 under the Exchange Act, except that in calculating the beneficial ownership of any particular “person” (as that term is used in
Section 13(d)(3) of the Exchange Act), such “person” will be deemed to have beneficial ownership of all securities that such “person” has the right to acquire by conversion or exercise of other securities, whether such right
is currently exercisable or is exercisable only after the passage of time. 
 “Board” means the Board of Directors of the
Company or, with respect to any action to be taken by the Board of Directors, any committee of the Board of Directors duly authorized to take such action. 

“Business Day” means any day other than a Saturday, Sunday, any federal legal holiday or day on which banking institutions in
the State of New York or State of Texas are authorized or required by law or other governmental action to close. 

  
 1 

 “Certificate of Designation” means the Certificate of Designation of 12%
Redeemable Preferred Stock of the Company, dated as of October 30, 2018. 
 “Closing Date” means
November 29, 2018. 
 “Common Share Price” means the volume weighted average closing price of Common Shares (as
reported by the NYSE or, if the NYSE is not the primary securities exchange or market for the Common Shares, such primary securities exchange or market) for the ten (10) trading days immediately preceding the date on which the determination is
made (or, if such price is not available, as determined in good faith by the Board). 
 “Common Shares” means the shares of
common stock, par value $1.00 per share, of the Company. 
 “Company” has the meaning specified therefor in the
introductory paragraph to this Agreement. 
 “Delay Notice” has the meaning specified therefor in Section 2.02. 

“Effective Date” means, with respect to a particular Shelf Registration Statement, the date of effectiveness of such Shelf
Registration Statement. 
 “Effectiveness Period” means, with respect to a Shelf Registration Statement, the period
beginning on the Effective Date for the Shelf Registration Statement and ending at the time all Registrable Securities the sale or distribution of which is covered by such Shelf Registration Statement shall have ceased to be Registrable Securities.

 “Electing Holders” has the meaning specified therefor in Section 2.03. 

“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC
promulgated thereunder. 
 “FINRA” has the meaning specified therefor in Section 2.04(f). 

“Governmental Authority” means any federal, state, local or foreign government, or other governmental, regulatory or
administrative authority, agency or commission or any court, tribunal, or judicial or arbitral body. 
 “Holder” means the
record holder of any Registrable Securities. 
 “Interruption Period” has the meaning specified therefor in
Section 2.04. 
 “Law” means any statute, law, ordinance, regulation, rule, order, code, governmental restriction,
decree, injunction or other requirement of law, or any judicial or administrative interpretation thereof, of any Governmental Authority. 

“Liquidated Damages Payments” has the meaning specified therefor in Section 2.11(a). 

“Losses” has the meaning specified therefor in Section 2.08(a). 

  
 2 

 “Managing Underwriter” means, with respect to an Underwritten Offering, the
book-running lead manager for an Underwritten Offering. 
 “NYSE” means the New York Stock Exchange. 

“Person” means any individual, corporation, company, voluntary association, partnership, joint venture, trust,
limited liability company, unincorporated organization, government or any agency, instrumentality or political subdivision thereof or any other form of entity. 

“Preferred Shares” means the shares of 12% Redeemable Preferred Stock, par value $1.00 per share, of the Company issued by
the Company to the Purchasers pursuant to the Purchase Agreement, and all securities issued upon division or combination of, or in substitution for, such shares of Series A preferred stock, including any Substantially Equivalent Security (as defined
in the Certificate of Designation). 
 “Purchase Agreement” has the meaning specified therefor in the recitals to this
Agreement. 
 “Purchasers” has the meaning specified therefor in the introductory paragraph to this Agreement. 

“Registrable Securities” means, subject to Section 1.02, (i) the Common Shares issued or issuable upon the
exercise of the Warrants and (ii) the Common Shares issued in lieu of a cash redemption payment as a result of a Cash Election (as defined in the Certificate of Designation). 

“Registrable Securities Amount” means the calculation based on the product of the Common Share Price times the number of
applicable Registrable Securities. 
 “Registration Default” has the meaning specified therefor in Section 2.11(a).

 “Registration Expenses” means the following expenses incident to the Company’s performance under or compliance with
this Agreement to effect the registration of Registrable Securities on a Shelf Registration Statement pursuant to Section 2.01 or an Underwritten Offering covered under this Agreement, and the disposition of such Registrable Securities,
including, all registration, filing, securities exchange listing and NYSE fees, all registration, filing, qualification and other fees and expenses of complying with securities or blue sky laws, fees of the FINRA, fees of transfer agents and
registrars, all word processing, duplicating and printing expenses, and the fees and disbursements of counsel and independent public accountants for the Company, including the expenses of any special audits or “comfort” letters required by
or incident to such performance and compliance, and up to $50,000 of reasonable and documented fees and expenses of one counsel for all Holders for Underwritten Offerings hereunder. 

“Required Holders” means Holders of greater than 50% of the Registrable Securities initially subject to this Agreement. 

“Resale Shelf Registration Statement” has the meaning specified therefor in Section 2.01(a). 

  
 3 

 “SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the U.S. Securities Act of 1933, as amended, and the rules and regulations of the SEC
promulgated thereunder. 
 “Selling Expenses” means all underwriting discounts and selling commissions or similar fees or
arrangements and related expenses allocable to the sale of the Registrable Securities, transfer taxes and fees and disbursements of counsel to the Selling Holders, except for the reasonable fees and disbursements of counsel for the Selling Holders
required to be paid by the Company pursuant to Section 2.08, if applicable. 
 “Selling Holder” means a Holder who is
selling Registrable Securities under a registration statement pursuant to the terms of this Agreement. 
 “Selling Holder
Indemnified Persons” has the meaning specified therefor in Section 2.08(a). 
 “Shelf Registration Statement”
means a registration statement under the Securities Act to permit the public resale of the Registrable Securities from time to time as permitted by Rule 415 under the Securities Act (or any successor or similar provision adopted by the SEC then
in effect), including the Resale Shelf Registration Statement or a Subsequent Shelf Registration Statement, as applicable. 

“Subsequent Shelf Registration Statement” has the meaning specified therefor in Section 2.01(b). 

“Underwritten Offering” means the offering (including an offering pursuant to a Shelf Registration Statement) in which
Registrable Securities are sold to one or more underwriters on a firm commitment basis for reoffering to the public or an offering that is a “bought deal” or “block trade” with one or more investment banks. 

“Underwritten Offering Notice” has the meaning specified therefor in Section 2.03. 

“Underwritten Offering Threshold” means $25 million of Registrable Securities (calculated based on the Registrable
Securities Amount of Common Shares). 
 “Warrants” means the Series A warrants, and all warrants issued upon division or
combination of, or in substitution for such warrants, issued pursuant to the Warrant Agreement, to be dated as of the Closing Date, among the Company, Computershare Inc. and Computershare Trust Company, N.A. (the “Warrant
Agreement”). 
 Section 1.02 Registrable Securities. Any Registrable Security shall cease to be a Registrable Security
at the earliest of the following: (a) when a registration statement covering the sale or distribution of such Registrable Security becomes or has been declared effective by the SEC and such Registrable Security has been sold or disposed of
pursuant to such effective registration statement; (b) when such Registrable Security has been sold or disposed of (excluding transfers or assignments by a Holder to an Affiliate) pursuant to Rule 144 under the Securities Act (or any
successor or similar provision adopted by the SEC then in effect) under circumstances in 

  
 4 

 
which all of the applicable conditions of Rule 144 (as then in effect) are met; (c) when such Registrable Security is held by the Company or one of its subsidiaries or ceases to be
outstanding (whether as a result of repurchase or cancellation); or (d) when such Registrable Security has been sold or disposed of in a private transaction in which the transferor’s rights under this Agreement are not assigned to the
transferee of such securities pursuant to Section 2.10. 
 Section 1.03 Rules of Construction. Unless the context otherwise
requires, as used in this Agreement: 
 (a) a defined term has the meaning assigned to it for all purposes of this Agreement, regardless of
where it is defined herein; 
 (b) “or” is not exclusive but shall be used in the inclusive sense of “and/or”; 

(c) defined terms and other words used in the singular shall be deemed to include the plural, and vice versa; 

(d) The terms “herein,” “hereof” and “hereunder” and words of similar import refer to this Agreement as a whole
and not to any particular Article, Section or other subdivision of this Agreement; 
 (e) when the words “include,”
“includes” or “including” are used herein, they shall be deemed to be followed by the phrase “without limitation”; 

(f) unless expressly qualified otherwise (e.g., by “Business” or “trading”), all references to “days” are
deemed to be references to calendar days; 
 (g) all references to Sections or Articles refer to Sections or Articles of this Agreement
unless otherwise indicated; and 
 (h) references to agreements or instruments, or to statutes or regulations, are to such agreements or
instruments, or statutes or regulations, as amended, supplemented or modified from time to time (or to successor statutes and regulations). 

ARTICLE II 
 REGISTRATION
RIGHTS 
 Section 2.01 Shelf Registration. 

(a) Resale Shelf Registration Statements. Within 90 days of the Closing Date, the Company shall use its commercially reasonable efforts
to prepare and file with the SEC a registration statement covering the sale or distribution from time to time by the Holders, on a delayed or continuous basis pursuant to Rule 415 of the Securities Act, to permit the public resale of all Registrable
Securities on the terms and conditions specified in this Section 2.01 (the “Resale Shelf Registration Statement”). If any additional Common Shares become Registrable Securities, the Company shall use its commercially reasonable
efforts to amend the Shelf Registration Statement, or file a new Shelf Registration Statement, within 10 days to include such additional Common Shares. The Resale Shelf Registration Statement shall not include the

  
 5 

 
Registrable Securities of any Person who is not a Holder under this Agreement. Each Resale Shelf Registration Statement filed with the SEC pursuant to this Section 2.01 shall be on Form S-3 or, if Form S-3 is not then available to the Company, on Form S-1 or such other form of registration statement
as is then available to effect a registration for resale of the Registrable Securities, covering the Registrable Securities, and shall contain a prospectus in such form as to permit any Selling Holder covered by such Resale Shelf Registration
Statement to sell such Registrable Securities pursuant to Rule 415 under the Securities Act (or any successor or similar provision adopted by the SEC then in effect) at any time beginning on the Effective Date for such Resale Shelf Registration
Statement and while such Resale Shelf Registration continues to be effective under the Securities Act. The Company shall use its commercially reasonable efforts to cause any Resale Shelf Registration Statement filed pursuant to this
Section 2.01 to be declared effective as soon as practicable after the filing thereof (it being agreed that each Resale Shelf Registration Statement shall be an automatic shelf registration statement that shall become effective upon filing with
the SEC pursuant to Rule 462(e) if Rule 462(e) is available to the Company), but in any event by the first anniversary of the Closing Date. 

(b) Subsequent Shelf Registration Statement. If a Shelf Registration Statement filed pursuant to this Agreement ceases to be effective
under the Securities Act for any reason at any time during the Effectiveness Period, the Company shall use its commercially reasonable efforts as promptly as is reasonably practicable to cause such Shelf Registration Statement to again become
effective under the Securities Act, and shall use its commercially reasonable efforts as promptly as is reasonably practicable to amend such Shelf Registration Statement in a manner reasonably expected to result in the withdrawal of any order of the
SEC suspending the effectiveness of such Shelf Registration Statement or file an additional registration statement (a “Subsequent Shelf Registration Statement”) for an offering to be made on a delayed or continuous basis pursuant to
Rule 415 of the Securities Act registering the resale from time to time by the Holders thereof of all securities that are Registrable Securities as of the time of such filing and not registered pursuant to another Shelf Registration Statement. If
the sale or distribution of any Registrable Securities is not included by the Company on the Resale Shelf Registration Statement, the Company shall, upon written request by the Required Holders, file a Subsequent Shelf Registration Statement. If a
Subsequent Shelf Registration Statement is filed, the Company shall use its commercially reasonable efforts to cause such Subsequent Shelf Registration Statement to become effective under the Securities Act as promptly as is reasonably practicable
after the filing thereof (it being agreed that the Subsequent Shelf Registration Statement shall be an automatic shelf registration statement that shall become effective upon filing with the SEC pursuant to Rule 462(e) if Rule 462(e) is available to
the Company) and (b) keep such Subsequent Shelf Registration Statement continuously effective until the end of the Effectiveness Period. Any such Subsequent Shelf Registration Statement shall be a registration statement on Form S-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration Statement shall be on another appropriate form and shall provide for the registration of such
Registrable Securities for resale by the Holders in accordance with any reasonable method of distribution elected by the Required Holders. 

(c) Effectiveness Period. A Shelf Registration Statement shall provide for the resale pursuant to any method or combination of methods
legally available to, and requested by, the Selling Holders, including by way of an Underwritten Offering, if such an election has been made pursuant to Section 2.03. During the Effectiveness Period, the Company shall, subject to the

  
 6 

 
applicable provisions of the Securities Act, use its commercially reasonable efforts to cause a Shelf Registration Statement filed pursuant to this Section 2.01 to remain effective, and to
be supplemented and amended to the extent necessary to ensure that such Shelf Registration Statement is available or, if not available, that another registration statement is available for the resale of the Registrable Securities until all
Registrable Securities have ceased to be Registrable Securities. The Company shall prepare and file all necessary information with the NYSE (or such other national securities exchange on which the Registrable Securities are then listed and traded)
to list the Registrable Securities covered by a Shelf Registration Statement and shall use its commercially reasonable efforts to have such Registrable Securities approved for listing on the NYSE (or such other national securities exchange on which
the Registrable Securities are then listed and traded) by the date of any sale or distribution of such Registrable Securities, subject only to official notice of issuance. As soon as practicable following the Effective Date of a Shelf Registration
Statement, but in any event within three Business Days of such date, the Company shall notify the Holders of the effectiveness of such Shelf Registration Statement. 

(d) Underwriting. If the Managing Underwriter of the proposed Underwritten Offering of Registrable Securities advises the Company that
the inclusion of all of the Selling Holders’ Registrable Securities that the Selling Holders intend to include in such offering exceeds the number that can be sold in such offering without being likely to have a material adverse effect on the
price, timing or distribution of the Registrable Securities offered or the market for the Registrable Securities, then the Registrable Securities to be included in an Underwritten Offering shall include the number of Registrable Securities that such
Managing Underwriter advises the Company can be sold without having such material adverse effect, with such number to be allocated to the Selling Holders, allocated among such Selling Holders pro rata on the basis of the number of Registrable
Securities held by each such Selling Holder or in such other manner as such Selling Holders may agree. 
 Section 2.02 Delay
Rights. Notwithstanding anything to the contrary contained herein, the Company may, upon written notice (a “Delay Notice”) to (i) all Holders, delay the filing of a Shelf Registration Statement required under
Section 2.01, or (ii) all Selling Holders whose Registrable Securities are included in a Shelf Registration Statement or other registration statement contemplated by this Agreement, suspend such Selling Holders’ use of any prospectus
that is a part of such Shelf Registration Statement or other registration statement (in which event the Selling Holder shall discontinue sales of the Registrable Securities pursuant to such Shelf Registration Statement or other registration
statement contemplated by this Agreement but may settle any previously made sales of Registrable Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition, financing, securities offering or
other similar transaction and the Board determines in good faith that (A) the Company’s ability to pursue or consummate such a transaction would be materially adversely affected by any required disclosure of such transaction in such Shelf
Registration Statement or other registration statement (in each case, including any document incorporated by reference therein) or (B) such transaction or the pursuit thereof renders the Company unable to comply with SEC requirements, in each
case under circumstances that would make it impractical or inadvisable to cause the Shelf Registration Statement (or such filings) to become effective or to promptly amend or supplement the Shelf Registration Statement on a post-effective basis, as
applicable, (y) has experienced some other material non-public event the disclosure of which at such time, in the good faith judgment of the Board, would materially adversely affect the Company or
(z) would, in the absence of such delay 

  
 7 

 
or suspension, either be required to prematurely disclose material information that the Company has a bona fide business purpose for preserving as confidential or would be rendered unable
to comply with the requirements under the Securities Act or the Exchange Act; provided, however, in no event shall (A) such filing of such Shelf Registration Statement be delayed under this Section 2.02 for a period that exceeds
90 calendar days or (B) such Selling Holders be suspended under this Section 2.02 from selling Registrable Securities pursuant to such Shelf Registration Statement or other registration statement for a period that exceeds an aggregate
of 90 calendar days in any 365 calendar-day period, in each case, exclusive of days covered by any lock-up agreement executed by a Selling Holder in connection
with an Underwritten Offering. The Holders agree to keep the existence and contents of any Delay Notice confidential and not to use such information for any other purpose. Upon disclosure of such information or the termination of the condition
described above, the Company shall provide prompt notice, but in any event within one Business Day of such disclosure or termination, to the Selling Holders whose Registrable Securities are included in such Shelf Registration Statement and shall
promptly terminate any suspension of sales it has put into effect and shall take such other reasonable actions to permit registered sales of Registrable Securities as contemplated in this Agreement. 

Section 2.03 Underwritten Offering. In the event that one or more Holders elect to sell or distribute at least an Underwritten
Offering Threshold in the aggregate pursuant to a Shelf Registration Statement pursuant to an Underwritten Offering of Common Shares, such Holder(s) shall deliver a written notice of such election to the Company (such request, an
“Underwritten Offering Notice,” and such electing Holders, the “Electing Holders”); provided, however, that the Required Holders shall have the option and right to require the
Company to effect not more than two Underwritten Offerings pursuant to and subject to the conditions of this Section 2.03. Upon delivery of such Underwritten Offering Notice to the Company, the Company shall as soon as practicable (but in no
event later than two Business Days following the date of delivery of an Underwritten Offering Notice to the Company) deliver notice of such Underwritten Offering Notice to all other Holders, who shall then have two Business Days (or one Business Day
in the case of an underwritten “bought deal” or “block trade”) from the date that such notice is given to them to notify the Company in writing of the number of Registrable Securities held by such Holder that they want to be
included in an Underwritten Offering. Upon receipt of an Underwritten Offering Notice, the Company shall as soon as practicable use its commercially reasonable efforts to facilitate an Underwritten Offering. In the case of an underwritten
“bought deal” or “block trade,” an Underwritten Offering Notice shall be given not less than three Business Days prior to the day the offering is to commence. In connection with an Underwritten Offering of Registrable Securities
under this Agreement, the Managing Underwriter or Underwriters shall be selected by the Electing Holders and shall be reasonably acceptable to the Company. In connection with an Underwritten Offering contemplated by this Agreement in which a Selling
Holder participates, each Selling Holder and the Company shall be obligated to enter into an underwriting agreement that contains such representations, warranties, covenants, indemnities and other rights and obligations as are customary in
underwriting agreements for firm commitment offerings of securities. No Selling Holder may participate in an Underwritten Offering unless such Selling Holder agrees to sell its Registrable Securities on the basis provided in such underwriting
agreement and completes and executes all questionnaires, powers of attorney, indemnities and other documents reasonably required under the terms of such underwriting agreement. No Selling Holder shall be required to make any representations or
warranties to or agreements with the Company or the underwriters other than representations, warranties or agreements regarding such 

  
 8 

 
Selling Holder, its authority to enter into such underwriting agreement and to sell, and its ownership of, the securities whose offer and resale will be registered, on its behalf, its intended
method of distribution and any other representation required by applicable Law. If any Selling Holder disapproves of the terms of an underwriting, such Selling Holder may elect to withdraw therefrom by notice to the Company, the Electing Holders and
the Managing Underwriter; provided, however, that any such withdrawal must be made no later than the time of pricing of an Underwritten Offering. If all Selling Holders withdraw from an Underwritten Offering prior to the pricing of an
Underwritten Offering or if the registration statement relating to an Underwritten Offering is suspended pursuant to Section 2.02, the events will not be considered to be an Underwritten Offering and the Holders will continue to have the right
and option to request an Underwritten Offering under this Section 2.03. No such withdrawal or abandonment shall affect the Company’s obligation to pay Registration Expenses pursuant to Section 2.07. 

Section 2.04 Sale Procedures. In connection with its obligations under this Article II, the Company shall, as expeditiously as
possible: 
 (a) prepare and promptly file with the SEC a Shelf Registration Statement with respect to any Registrable Securities and use
commercially reasonable efforts to cause such Shelf Registration Statement to become and remain effective for the Effectiveness Period, in accordance with and subject to the applicable provisions of this Agreement and the Securities Act; 

(b) furnish to the Holders’ legal counsel copies of each Shelf Registration Statement and the prospectus included therein (including each
preliminary prospectus) proposed to be filed and provide such legal counsel a reasonable opportunity to review and comment on any such Shelf Registration Statement; 

(c) prepare and file with the SEC such amendments (including post-effective amendments) and supplements to any Shelf Registration Statement and
the prospectus used in connection herewith as may be necessary to keep any such Shelf Registration Statement effective for the Effectiveness Period and as may be necessary to comply with the provisions of the Securities Act with respect to the
disposition of all Registrable Securities covered by any such Shelf Registration Statement in accordance with the Selling Holders’ intended method of distribution set forth in such Shelf Registration Statement; 

(d) to the extent not publicly available, furnish or otherwise make available to each Selling Holder (i) as far in advance as reasonably
practicable before filing a Shelf Registration Statement or any other registration statement contemplated by this Agreement or any supplement or amendment thereto, upon request, copies of reasonably complete drafts of all such documents proposed to
be filed (including exhibits and each document incorporated by reference therein to the extent then required by the rules and regulations of the SEC other than annual or quarterly reports on Forms 10-K or
10-Q, respectively, current reports on Form 8-K or proxy statements; provided, however, that such reports or proxy statements shall be provided at
least two Business Days prior to filing in connection with an Underwritten Offering), and provide each such Selling Holder the opportunity to object to any information pertaining to such Selling Holder and its plan of distribution that is contained
therein and make the corrections reasonably requested by such Selling Holder with respect to such information prior to filing a Shelf Registration Statement or such other registration statement or supplement or amendment thereto, and (ii) such
number of 

  
 9 

 
copies of such Registration Statement or such other registration statement and the prospectus included therein and any supplements and amendments thereto as such Selling Holder may reasonably
request in order to facilitate the public sale or other disposition of the Registrable Securities covered by such Shelf Registration Statement or other registration statement; 

(e) if applicable, use its commercially reasonable efforts to register or qualify the Registrable Securities covered by a Shelf Registration
Statement or any other registration statement contemplated by this Agreement under the securities or blue sky laws of such jurisdictions as the Selling Holders or, in the case of an Underwritten Offering, the Managing Underwriter, shall reasonably
request; provided, however, that the Company shall not be required to qualify generally to transact business in any jurisdiction where it is not then required to so qualify or to take any action that would subject it to general service of
process or taxation in any such jurisdiction where it is not then so subject; 
 (f) cooperate with the Selling Holders and each underwriter
or agent participating in the disposition of Registrable Securities and their respective counsel in connection with any filings required to be made with Financial Industry Regulatory Authority, Inc. (“FINRA”), including the use of
commercially reasonable efforts to obtain FINRA’s pre-clearance or pre-approval of the registration statement and applicable prospectus upon filing with the SEC;

 (g) upon request and subject to appropriate confidentiality obligations, furnish to each Selling Holder copies of any and all transmittal
letters or other material correspondence with the SEC or any other governmental agency or self-regulatory body or other body having jurisdiction (including any domestic or foreign securities exchange) relating to such offering of Registrable
Securities; 
 (h) promptly notify each Selling Holder, at any time when a prospectus relating thereto is required to be delivered by any of
them under the Securities Act, of (i) the filing of a Shelf Registration Statement or any other registration statement contemplated by this Agreement or any prospectus or prospectus supplement to be used in connection therewith, or any
amendment or supplement thereto, and, with respect to such Shelf Registration Statement or any other registration statement or any post-effective amendment thereto, when the same has become effective; (ii) the receipt of any written comments
from the SEC with respect to any filing referred to in clause (i); and (iii) any written request by the SEC for amendments or supplements to such Shelf Registration Statement or any other registration statement or any prospectus or
prospectus supplement thereto or for additional information; 
 (i) promptly notify each Selling Holder, at any time when a prospectus
relating thereto is required to be delivered under the Securities Act, of (i) the happening of any event as a result of which the prospectus or prospectus supplement contained in a Shelf Registration Statement or any other registration
statement contemplated by this Agreement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading (in the case of
any prospectus contained therein, in the light of the circumstances under such statements are made); (ii) the issuance or express threat of issuance by the SEC of any stop order suspending the effectiveness of such Shelf Registration Statement
or any other registration statement contemplated by this Agreement, or the initiation of any proceedings for that purpose; or (iii) the receipt by the Company of any 

  
 10 

 
notification with respect to the suspension of the qualification of any Registrable Securities for sale under the applicable securities or blue sky laws of any jurisdiction. Following the
provision of such notice, the Company agrees to as promptly as practicable amend or supplement the prospectus or prospectus supplement or take other appropriate action so that the prospectus or prospectus supplement does not include an untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they are made and to take such other commercially
reasonable action as is necessary to remove a stop order, suspension, threat thereof or proceedings related thereto; 
 (j) in connection
with a customary due diligence review, make available for inspection by any Selling Holder, any Managing Underwriter or any other underwriter participating in any such disposition of Registrable Securities, and any counsel or accountants retained by
such Selling Holder, Managing Underwriter or underwriter, at the offices where normally kept, during reasonable business hours, all financial and other records, pertinent corporate documents of the Company and its subsidiaries, and cause the
officers, directors and employees of the Company and its subsidiaries to supply all information and participate in customary due diligence sessions in each case reasonably requested by any such Selling Holder, Managing Underwriter, underwriter,
counsel or accountant in connection with such Registration Statement, subject to appropriate confidentiality obligations; 
 (k) in the case
of an Underwritten Offering, use its commercially reasonable efforts to furnish to the underwriters, (i) an opinion of counsel for the Company dated the date of the closing under the underwriting agreement, addressed to the underwriters, and
(ii) a customary “comfort” letter, dated the pricing date of an Underwritten Offering and a “bring-down” comfort letter dated the date of the closing under the underwriting agreement, in each case addressed to the
underwriters, signed by the independent public accountants who have certified the Company’s financial statements included or incorporated by reference into the applicable registration statement, and each of the opinion and the
“comfort” letter shall be in customary form and covering substantially the same matters with respect to such registration statement (and the prospectus and any prospectus supplement included therein) as have been customarily covered in
opinions of issuer’s counsel and in accountants’ letters delivered to the underwriters in underwritten offerings of securities by the Company and such other matters as such underwriters may reasonably request; 

(l) in the event that the Registrable Securities are being offered in an Underwritten Offering, enter into an underwriting agreement in
accordance with the applicable provisions of this Agreement; provided, however, that no underwriting agreement shall require: (1) the Company to enter into a lock-up agreement unless (i) such
underwriting agreement is executed in connection with an Underwritten Offering of Common Shares and (ii) the lock-up agreement required under such underwriting agreement does not exceed 60 days from the
date of the pricing of such offering and contains customary exceptions from the Company’s own immediately preceding underwritten offering; or (2) the officers, directors or any Affiliate of the Company to enter into a lock-up agreement; 
 (m) otherwise use its commercially reasonable efforts to comply with all applicable
rules and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable, an earnings statement, covering a period of 12 months beginning within three months after the Effective Date of such Shelf Registration
Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 promulgated thereunder; 

  
 11 

 (n) use its commercially reasonable efforts to cause all such Registrable Securities
registered pursuant to this Agreement to be listed on the primary securities exchange or nationally recognized quotation system on which such Registrable Securities are then listed or quoted; 

(o) use its commercially reasonable efforts to cause the Registrable Securities to be registered with or approved by such other governmental
agencies or authorities as may be necessary by virtue of the business and operations of the Company to enable the Selling Holders to consummate the disposition of such Registrable Securities; 

(p) provide a transfer agent and registrar for all Registrable Securities covered by such registration statement not later than the Effective
Date of such registration statement; 
 (q) enter into customary agreements and take such other actions as are reasonably requested by the
Selling Holders or the underwriters, if any, in order to expedite or facilitate the disposition of such Registrable Securities (including, in the case of an Underwritten Offering, making appropriate officers of the Company available to participate
in no more than one telephonic “road show” presentation before analysts), and other customary marketing activities (including one-on-one conference calls with
prospective purchasers of the Registrable Securities)); and 
 (r) if requested by the Managing Underwriter or underwriters, or any Selling
Holder, (i) as soon as practicable incorporate in a prospectus supplement or post-effective amendment such information as the Managing Underwriter or underwriters, or any Selling Holder reasonably requests to be included therein relating to the
sale and distribution of Registrable Securities, including information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering of the Registrable
Securities to be sold in such offering, and (ii) as soon as practicable make all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or
post-effective amendment. 
 The Company shall not name a Holder as an underwriter as defined in Section 2(a)(11) of the Securities Act
in any Shelf Registration Statement without such Holder’s consent. 
 Each Selling Holder, upon receipt of notice from the Company of
the happening of any event of the kind described in Section 2.04(h)(iii) or Section 2.04(i) shall forthwith discontinue offers and sales of the Registrable Securities by means of a prospectus or prospectus supplement until such Selling
Holder’s receipt of the copies of the supplemented or amended prospectus contemplated by Section 2.04(h)(iii) or Section 2.04(i) or until it is advised in writing by the Company that the use of the prospectus may be resumed and has
received copies of any additional or supplemental filings incorporated by reference in the prospectus (such period during which disposition is discontinued being an “Interruption Period”), and, if so directed by the Company, such
Selling Holder shall, or shall request the Managing Underwriter, if any, to deliver to the Company (at the Company’s expense) all copies in their possession or control, other than permanent file copies then in such Selling Holder’s
possession, of the prospectus covering such Registrable Securities current at the time of receipt of such notice. As soon as practicable after the 

  
 12 

 
Company has determined that the use of the applicable prospectus may be resumed, the Company will notify the Selling Holders thereof. In the event the Company invokes an Interruption Period
hereunder and, in the discretion of the Company, the need for the Company to continue the Interruption Period ceases for any reason, the Company shall, as soon as reasonably practicable, provide written notice to the Selling Holders that such
Interruption Period is no longer applicable. 
 Section 2.05 Cooperation by Holders. The Company shall have no obligation to
include Registrable Securities of a Holder in a registration statement who has failed to timely furnish after receipt of a written request from the Company such information that the Company determines, after consultation with its counsel, is
reasonably required in order for the registration statement or prospectus supplement, as applicable, to comply with the applicable provisions of the Securities Act. 

Section 2.06 Restrictions on Sales. To the extent requested by the Managing Underwriter, each Holder of Registrable Securities
that participates in an Underwritten Offering will enter into a customary letter agreement with underwriters providing such Holder will not effect any public sale or distribution of Registrable Securities during the period of 60 days beginning on
the date of a prospectus or prospectus supplement filed with the SEC with respect to the pricing of an Underwritten Offering, provided that (i) the duration of the foregoing restrictions shall be no longer than the duration of the
shortest restriction generally imposed by the underwriters on the Company and (ii) the restrictions set forth in this Section 2.06 shall not apply to any Registrable Securities that are included in an Underwritten Offering by such Holder.

 For the avoidance of doubt, this Section 2.06 shall not apply to any Holder that does not elect to participate in an Underwritten
Offering. 
 Section 2.07 Expenses. The Company shall pay all reasonable Registration Expenses, as determined in good faith by
the Board, including, in the case of an Underwritten Offering, the Registration Expenses of an Underwritten Offering, regardless of whether any sale is made pursuant to an Underwritten Offering. Each Selling Holder shall pay its pro rata
share of all Selling Expenses in connection with any sale of its Registrable Securities hereunder. For the avoidance of doubt, each Selling Holder’s pro rata allocation of Selling Expenses shall be the percentage derived by dividing
(i) the number of Registrable Securities sold by such Selling Holder in connection with such sale by (ii) the aggregate number of Registrable Securities sold by all Selling Holders in connection with such sale. In addition, except as
otherwise provided in this Section 2.07 and Section 2.08, the Company shall not be responsible for legal fees incurred by Holders in connection with the exercise of such Holders’ rights hereunder. 

Section 2.08 Indemnification. 

(a) By the Company. In the event of a registration of any Registrable Securities under the Securities Act pursuant to this Agreement,
the Company shall indemnify and hold harmless each Selling Holder thereunder, and its directors, officers, managers, employees, agents and Affiliates and each Person, if any, who controls such Selling Holder or its Affiliates within the meaning of
the Securities Act and the Exchange Act, and its directors, officers, employees or agents (collectively, the “Selling Holder Indemnified Persons”), against any losses, claims, damages, expenses or liabilities (including reasonable
attorneys’ fees and expenses) (collectively, 

  
 13 

 
“Losses”), joint or several, to which such Selling Holder Indemnified Person may become subject under the Securities Act, the Exchange Act or otherwise, insofar as such Losses
(or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact (in the case of any prospectus, in light of the circumstances under
which such statement is made) contained in (which, for the avoidance of doubt, includes documents incorporated by reference in) any registration statement contemplated by this Agreement, any preliminary prospectus, prospectus supplement or final
prospectus contained therein, or any amendment or supplement thereof, or any free writing prospectus relating thereto or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein (in the case of a prospectus, in light of the circumstances under which they were made) not misleading, and the Company shall reimburse each such Selling Holder Indemnified Person for any legal or other
expenses reasonably incurred by them in connection with investigating, defending or resolving any such Loss or actions or proceedings; provided, however, that the Company shall not be liable in any such case if and to the extent that any such
Loss arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by such Selling Holder Indemnified Person in writing specifically for use in any
such document. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Selling Holder Indemnified Person, and shall survive the transfer of such securities by such Selling Holder. 

(b) By Each Selling Holder. Each Selling Holder agrees severally and not jointly to indemnify and hold harmless the Company, its
directors, officers, employees and agents and each Person, if any, who controls the Company within the meaning of the Securities Act or of the Exchange Act, and its directors, officers, employees and agents, to the same extent as the foregoing
indemnity from the Company to the Selling Holders, but only with respect to information regarding such Selling Holder furnished in writing by or on behalf of such Selling Holder expressly for inclusion in any registration statement contemplated by
this Agreement, any preliminary prospectus, prospectus supplement or final prospectus contained therein, or any amendment or supplement thereof, or any free writing prospectus relating thereto; provided, however, that the liability of
each Selling Holder shall not be greater in amount than the dollar amount of the proceeds (net of any Selling Expenses) received by such Selling Holder from the sale of the Registrable Securities giving rise to such indemnification. 

(c) Notice. Promptly after receipt by an indemnified party hereunder of notice of the commencement of any action, such indemnified party
shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party in writing thereof, but the omission to so notify the indemnifying party shall not relieve it from any liability that it may
have to any indemnified party under this Section 2.08 except to the extent that the indemnifying party is materially prejudiced in its ability to defend such action by such failure. In any action brought against any indemnified party, it shall
notify the indemnifying party of the commencement thereof. The indemnifying party shall be entitled to participate in and, to the extent it shall wish, to assume and undertake the defense thereof with counsel reasonably satisfactory to such
indemnified party and, after notice from the indemnifying party to such indemnified party of its election so to assume and undertake the defense thereof, the indemnifying party shall not be liable to such indemnified party under this
Section 2.08 for any legal expenses subsequently incurred by such indemnified party in connection with the defense thereof; provided, however, 

  
 14 

 
that, (i) if the indemnifying party has failed to assume the defense or employ counsel reasonably acceptable to the indemnified party or (ii) if the defendants in any such action
include both the indemnified party and the indemnifying party and counsel to the indemnified party shall have concluded that there may be reasonable defenses available to the indemnified party that are different from or additional to those available
to the indemnifying party, or if the interests of the indemnified party reasonably may be deemed to conflict with the interests of the indemnifying party, then the indemnified party shall have the right to select one separate counsel and to assume
such legal defense and otherwise to participate in the defense of such action, with the reasonable expenses and fees of such separate counsel and other reasonable expenses related to such participation to be reimbursed by the indemnifying party as
incurred. Notwithstanding any other provision of this Agreement, no indemnifying party shall settle any action brought against any indemnified party with respect to which such indemnified party is entitled to indemnification hereunder without the
consent of the indemnified party (which shall not be unreasonably withheld, delayed or conditioned), unless the settlement thereof imposes no liability or obligation on, and includes a complete and unconditional release from all liability of, the
indemnified party. In addition, no indemnifying party shall be liable for the settlement of any action effected without its prior written consent (which shall not be unreasonably withheld, delayed or conditioned). 

(d) Contribution. If the indemnification provided for in this Section 2.08 is held by a court or government agency of competent
jurisdiction to be unavailable to any indemnified party or is insufficient to hold them harmless in respect of any Losses, then each such indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or
payable by such indemnified party as a result of such Loss in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of such indemnified party on the other in connection with the statements or
omissions that resulted in such Losses, as well as any other relevant equitable considerations; provided, however, that in no event shall such Selling Holder be required to contribute an aggregate amount in excess of the dollar amount
of proceeds (net of Selling Expenses) received by such Selling Holder from the sale of Registrable Securities giving rise to such indemnification. The relative fault of the indemnifying party on the one hand and the indemnified party on the other
shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact has been made by, or relates to, information supplied by such
party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The parties hereto agree that it would not be just and equitable if contributions pursuant to this
paragraph were to be determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to herein. No person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who is not guilty of such fraudulent misrepresentation. 

(e) Other Indemnification. The provisions of this Section 2.08 shall be in addition to any other rights to indemnification or
contribution that an indemnified party may have pursuant to applicable Law, contract or otherwise. 
 Section 2.09 Rule 144
Reporting. With a view to making available the benefits of certain rules and regulations of the SEC that may permit the sale of the Registrable Securities to the public without registration, the Company agrees to use its commercially reasonable
efforts to: 

  
 15 

 (a) make and keep public information regarding the Company available, as those terms are
understood and defined in Rule 144 under the Securities Act (or any successor or similar provision adopted by the SEC then in effect), at all times from and after the date hereof; 

(b) file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act
at all times from and after the date hereof; and 
 (c) so long as a Holder owns any Registrable Securities, furnish, unless otherwise
available electronically at no additional charge via the SEC’s EDGAR system, to such Holder forthwith upon request a copy of the most recent annual or quarterly report of the Company, and such other reports and documents as such Holder may
reasonably request in availing itself of any rule or regulation of the SEC allowing such Holder to sell any such securities without registration. 

Section 2.10 Transfer or Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities
granted to the Purchasers by the Company under this Article II may be transferred or assigned by the Purchasers to one or more transferees or assignees of Registrable Securities without the consent of the Company; provided, however, that,
(a) the transfer or assignment relates to a transfer or assignment of Warrants made in accordance with the applicable provisions of the Warrant Agreement, (b) any such transfer or assignment is for a number of Registrable Securities
representing an aggregate Registrable Securities Amount of at least $5 million or any such transfer or assignment is to a Permitted Transferee (as defined in the Purchase Agreement), (c) the Company is given written notice prior to any
said transfer or assignment, stating the name and address of each of the transferee or assignee, (d) each such transferee or assignee assumes in writing responsibility for its portion of the obligations of the Purchasers under this Agreement
and (e) the transferor or assignor is not relieved of any obligations or liabilities hereunder arising out of events occurring prior to such transfer. 

Section 2.11 Liquidated Damages Payments Under Certain Circumstances. 

(a) Payments (“Liquidated Damages Payments”) with respect to the Registrable Securities required to be covered by the Resale
Shelf Registration Statement shall be assessed if the Resale Shelf Registration Statement has not been declared effective by the first anniversary of the Closing Date (a “Registration Default”). Liquidated Damages Payments shall
accrue on such Registrable Securities (based on the Common Share Price as of such Business Day) for each such day from and including the date on which any such Registration Default occurs to but excluding the date on which all such Registration
Defaults have been cured, at a rate of 6% per annum. Liquidated Damages Payments shall be paid in accordance with Section 2.11(c) below. Other than the obligation of payment of any Liquidated Damages Payments in accordance with the terms
hereof, the Company will have no other liabilities for monetary damages with respect to its registration obligations. With respect to each Holder, the Company’s obligations to pay Liquidated Damages Payments remain in effect only so long as the
securities held by the Holder are Registrable Securities. 
 (b) In the event the Company provides a Delay Notice pursuant to
Section 2.02, a Registration Default shall be deemed not to have occurred and be continuing, and no Liquidated Damages Payments shall accrue as a result thereof, in relation to the Resale Shelf Registration Statement or the related prospectus,
until the end of the 90-day period described in Section 2.02. 

  
 16 

 (c) Any amounts of Liquidated Damages Payments due pursuant to this Section 2.11 will
be payable in cash to the applicable Holders on the regular dividend payment dates described in the Certificate of Designation; provided, however, to the extent the Company is unable to pay Liquidated Damages Payments in cash because such
payment would result in a breach under a credit facility or other debt instrument, then the Company will pay such Liquidated Damages Payments using as much cash as the Company is permitted without causing a breach of or default under such credit
facility or other debt instrument. The amount of Liquidated Damages Payments will be determined on the basis of a 360-day year comprised of twelve 30-day months and the
actual number of days on which Liquidated Damages Payments accrued during such period. 
 Section 2.12 Limitations on Subsequent
Registration Rights. From and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders, enter into any agreement with any current or future holder of any securities of the Company that would
provide such holder with rights that would allow such holder to participate with respect to any registration for the benefit of the Holders pursuant to this Agreement. 

ARTICLE III 

MISCELLANEOUS 

Section 3.01 Termination and Effect of Termination. This Agreement shall terminate with respect to each Holder on the date as of
which such Holder no longer holds any Registrable Securities (including, for the avoidance of doubt, Warrants the Common Shares issuable upon exercise of which Warrants would be Registrable Securities) and will terminate in full on the date as of
which no Holder holds any Registrable Securities, except for the provisions of Section 2.06 and Section 2.07, which shall survive any such termination. No termination under this Agreement shall relieve any Person of liability for
Registration Expenses or Selling Expenses incurred prior to termination. In the event this Agreement is terminated, each Person entitled to indemnification or contribution rights pursuant to Section 2.08 shall retain such rights with respect to
any matter that (i) may be an indemnified liability thereunder and (ii) occurred prior to such termination. 
 Section 3.02
Notices and Communications. Any notice or communication by the Company, on the one hand, or any of the Holders, on the other hand, to the other shall be in writing and shall be deemed to have been duly given and received (i) when
delivered in person, (ii) when actually received when mailed by first class mail, postage prepaid, (iii) when actually received by overnight delivery by a nationally recognized courier service, or (iv) when receipt has been
acknowledged when sent via electronic mail “email”). In each case the notice or communication shall be addressed as follows: 
 (a)
if to the Purchasers: 
 West Street Capital Partners VII Offshore Investments, L.P. 

c/o Goldman Sachs & Co. LLC 

200 West Street 
 New York, NY
10282 
 Attention: Chris Crampton 

  
 17 

 with a copy to: 

Goldman Sachs & Co. LLC 

200 West Street 
 New York, NY
10282 
 Attention: General Counsel, Merchant Banking Division 

with a copy (which shall not constitute notice) to: 

Vinson & Elkins L.L.P. 

666 Fifth Avenue, 26th Floor 

New York, NY 10103 
 Attention:
Caroline Blitzer Phillips 
 Email: cphillips@velaw.com 

(b) if to a transferee of a Purchaser, to such Holder at the address provided pursuant to Section 2.10 above; and 

(c) if to the Company: 

McDermott International, Inc. 

757 N. Eldridge Parkway 

Houston, TX 77079 
 Attention:
John Freeman 
 Email: jfreeman@mcdermott.com 

with copies (which shall not constitute notice) to: 

Baker Botts L.L.P. 
 910
Louisiana Street 
 Houston, TX 77002 

Attention: Ted W. Paris 
 James
H. Mayor 
 Email: ted.paris@bakerbotts.com 

james.mayor@bakerbotts.com 
 or to such other
address as any such party may designate in writing by notice delivered to the other parties hereto in accordance with this Section 3.02. 

Section 3.03 Entire Agreement. This Agreement is intended by the parties hereto as a final expression of their agreement and
intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter hereof. There are no restrictions, promises, representations, warranties or undertakings, other than those
set forth or referred to herein, with respect to the rights granted by the Company set forth herein. This Agreement supersedes all prior written or oral agreements and understandings among the parties hereto with respect to such subject matter. 

  
 18 

 Section 3.04 Amendments and Waivers. This Agreement may be amended only by means
of a written amendment signed by the Company and the Holders of greater than 50% of the Registrable Securities then outstanding that are Common Shares issued or issuable upon the exercise of the Warrants; provided that any amendment of any of
the provisions of this Agreement which disproportionately materially adversely affects any Holder shall not be effective without the written approval of such Holder. Any Holder may (with respect to itself), at any time: (i) extend the time for
the performance of any of the obligations of the Company; or (ii) waive compliance by the Company with any of its agreements or covenants contained herein. The Company may, at any time: (i) extend the time for the performance of any of the
obligations or other acts of any Holder; and (ii) waive compliance by any Holder with any of its agreements or covenants contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing signed by the
party to be bound thereby. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of Holders of Registrable Securities whose securities are to be
offered or distributed pursuant to a Registration Statement, and that does not affect the rights of other Holders, may be given by Holders of greater than 50% of the Registrable Securities to be offered or distributed by such Holders pursuant to
such Registration Statement. 
 Section 3.05 Binding Effect; Benefits of This Agreement. This Agreement shall inure to the
benefit of and be binding upon each of the parties hereto and their respective successors and assigns, including subsequent Holders of Registrable Securities (but only to the extent expressly permitted herein); and, except as expressly provided in
Section 2.08, nothing in this Agreement, express or implied, is intended to confer upon any other Person any legal or equitable right, remedy or claim of any nature whatsoever under or by reason of this Agreement. 

Section 3.06 Assignment of Holders’ Rights. All or any portion of the rights and obligations of the Purchasers
under this Agreement may be transferred or assigned by each such Purchaser only in accordance with Section 2.10. 
 Section 3.07
Recapitalization, Exchanges, Etc. The provisions of this Agreement shall apply to the full extent set forth herein with respect to any and all equity interests of the Company or any successor or assign of the Company (whether by merger,
consolidation, sale of assets or otherwise) that may be issued in respect of, in exchange for or in substitution of, the Registrable Securities, and shall be appropriately adjusted for any combinations, share splits, recapitalizations, pro rata
distributions of shares and the like occurring after the date of this Agreement. 
 Section 3.08 Specific Performance. Damages
in the event of breach of this Agreement by a party hereto may be difficult, if not impossible, to ascertain, and it is therefore agreed that each such party, in addition to and without limiting any other remedy or right it may have, shall have the
right to seek an injunction or other equitable relief in a court of competent jurisdiction in accordance with Section 3.09, enjoining any such breach, and enforcing specifically the terms and provisions hereof, and each of the parties hereto,
to the extent permitted by applicable Law, hereby waives any and all defenses it may have on the ground of lack of jurisdiction or competence of the court to grant such an injunction or other equitable relief. The existence of this right shall not
preclude any such party from pursuing any other rights and remedies at law or in equity that such party may have. 

  
 19 

 Section 3.09 Governing Law; Jurisdiction and Venue; Waiver of Jury Trial. This
Agreement shall be governed by and construed in accordance with the laws of the State of New York (without giving effect to any principles of conflicts of laws thereof that would result in the application of the laws of any other jurisdiction,
except to the extent that the New York conflicts of laws principles would apply applicable Laws of the Republic of Panama to internal matters relating to corporations organized thereunder). The Company and each Holder of a Registrable Security each
hereby irrevocably and unconditionally: 
 (a) submits for itself in any legal action or proceeding relating solely to this Agreement or the
transactions contemplated hereby, to the exclusive jurisdiction of the courts of the State of New York and the Federal courts of the United States of America, in each case located within the Southern District of New York, and appellate courts
thereof; 
 (b) consents that any such action or proceeding may be brought in such courts, and waives any objection that it may now or
hereafter have to the venue of any such action or proceeding in any such court or that such action or proceeding was brought in an inconvenient court and agrees not to plead or claim the same to the extent permitted by applicable law; 

(c) agrees that service of process in any such action or proceeding may be effected by mailing a copy thereof by registered or certified mail
(or any substantially similar form of mail), postage prepaid, to the party, as the case may be, at its address set forth herein or in the applicable register for the Registrable Securities or at such other address of which the other party shall have
been notified pursuant hereto; 
 (d) agrees that nothing herein shall affect the right to effect service of process in any other manner
permitted by applicable Law or shall limit the right to sue in any other jurisdiction for recognition and enforcement of any judgment or if jurisdiction in the courts referenced in the foregoing clause (a) are not available despite the
intentions of the parties hereto; 
 (e) agrees that final judgment in any such suit, action or proceeding brought in such a court may be
enforced in the courts of any jurisdiction to which such party is subject by a suit upon such judgment, provided that service of process is effected upon such party in the manner specified herein or as otherwise permitted by applicable Law; 

(f) agrees that to the extent that such party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal
process with respect to itself or its property, such party hereby irrevocably waives such immunity in respect of its obligations under this Agreement, to the extent permitted by applicable Law; and 

(g) IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING IN RELATION TO THIS AGREEMENT. 

Section 3.10 Severability. Any provision of this Agreement that is invalid, illegal or unenforceable in any jurisdiction shall, as
to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without invalidating the remaining provisions hereof or affecting or impairing the validity or enforceability of such provision in any other
jurisdiction. 

  
 20 

 Section 3.11 Counterparts. This Agreement may be executed in any number of
counterparts and by different parties hereto in separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original and all of which counterparts, taken together, shall constitute but one and the same
Agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or .pdf attachment to electronic mail shall be effective as delivery of a manually executed counterpart to this Agreement. 

Section 3.12 Table of Contents and Headings. The Table of Contents and headings of the Articles and Sections of this Agreement
have been inserted for convenience of reference only, and shall not limit or otherwise affect the meaning hereof. 
 Section 3.13 No
Adverse Interpretation of Other Agreements. This Agreement may not be used to interpret another agreement of the Company, and no such agreement may be used to interpret this Agreement. 

Section 3.14 No Presumption. If any claim is made by a party hereto relating to any conflict, omission or ambiguity in this
Agreement, no presumption or burden of proof or persuasion shall be implied by virtue of the fact that this Agreement was prepared by or at the request of a particular party or its counsel. 

Section 3.15 Obligations Limited to Parties to This Agreement. Each of the parties hereto covenants, agrees and acknowledges that,
other than as set forth herein, no Person other than the Holders, their respective permitted assignees and the Company shall have any obligation hereunder and that, notwithstanding that one or more of such Persons may be a corporation, partnership
or limited liability company, no recourse under this Agreement or under any documents or instruments delivered in connection herewith shall be had against any former, current or future director, officer, employee, agent, general or limited partner,
manager, member, stockholder or Affiliate of any of such Persons or their respective permitted assignees, or any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of
any of the foregoing, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any applicable Law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be
imposed on or otherwise be incurred by any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of any of such Persons or any of their respective assignees, or any
former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of any of the foregoing, as such, for any obligations of such Persons or their respective permitted assignees under
this Agreement or any documents or instruments delivered in connection herewith or for any claim based on, in respect of or by reason of such obligation or its creation, except, in each case, for any assignee of any Holder hereunder. 

(Signature pages follow) 

  
 21 

 IN WITNESS WHEREOF, the parties hereto execute this Agreement, effective as of the date
first above written. 
  

			
	MCDERMOTT INTERNATIONAL, INC.
		
	By:	 	 /s/ Stuart Spence

		 	Stuart Spence
		 	Executive Vice President and Chief Financial Officer

  
 [Signature Page to
Registration Rights Agreement] 

 
			
	PURCHASERS:
	
	WEST STREET CAPITAL PARTNERS VII OFFSHORE INVESTMENTS, L.P.
	
	By: Goldman Sachs & Co. LLC, Duly Authorized Agent of the General Partner
		
	By:	 	 /s/ Chris Crampton

		 	Name: Chris Crampton
		 	Title: Managing Director
	
	WEST STREET CAPITAL PARTNERS VII INVESTMENTS B, L.P.
	
	By: Goldman Sachs & Co. LLC, Duly Authorized Agent of the General Partner
		
	By:	 	 /s/ Chris Crampton

		 	Name: Chris Crampton
		 	Title: Managing Director
	
	WEST STREET CAPITAL PARTNERS VII – PARALLEL B, L.P.
	
	By: Goldman Sachs & Co. LLC, Duly Authorized Agent of the General Partner
		
	By:	 	 /s/ Chris Crampton

		 	Name: Chris Crampton
		 	Title: Managing Director

  
 [Signature Page to
Registration Rights Agreement]EXHIBIT 10.6(f)

 

PARS AWARD AGREEMENT

(Omnibus Form, Last Revised 8/29/18)

 

	To:	______________ (“you”)
	 	 
	From:	Human Resources and Compensation Committee of the Board of Directors (the “Committee”)
	 	 
	Subject:	ESCO Technologies Inc. 2018 Omnibus Incentive Plan (“Plan”) –
	 	20__ Award (“Award”)

 

1. Award. Effective ________, 20__ (the “Effective
Date”) the Committee has awarded to you ______ Performance-Accelerated Restricted Share Units (the “PARS Units”)
pursuant to the Plan, representing the right to receive ______ shares of Company Stock (net of tax withholdings) upon satisfaction
of all of the terms and conditions set forth in this Award Agreement and in the Plan, a copy of which has been delivered to you.

 

2. Payout Terms.

 

(a)          If
you are continuously employed by the Company or a subsidiary, limited liability company, other entity directly or indirectly wholly
owned by the Company (“Company Owned Entity”) from the Effective Date through the close of business on the “Vesting
Date” as defined in the following paragraphs, you will become entitled to receive one share of Company Stock for each PARS
Unit, and such shares of Company Stock will be issued to you (net of tax withholdings) as of the next business day after the Vesting
Date.

 

(b)          The
Vesting Date is _________, 20__. However, the Vesting Date may be accelerated as to all or part of the PARS Units upon the occurrence
of one or more of the conditions set forth in paragraph 2(c) and/or 2(d).

 

(c)          Notwithstanding
paragraph 2(b), if, as of any date during the two-year period commencing ________, 20__ and ending _________, 20__, the 30-Day
Average Value Per Share of Company Stock reaches an amount set forth in column (A) below, the Vesting Date for the corresponding
percentage of the PARS Units set forth under column (B) below will be accelerated according to the following schedule:

 

	Acceleration Period	 	Vesting Date
	_________ – _________	 	_________
	_________ – _________	 	_________
	After _________	 	_________

 

	(A) 
If the 30-Day Average Value Per Share of
    
 Company Stock reaches at least:	 	(B) 
The Cumulative Percent of Award

    Accelerated shall be:	 
	$_____	 	 	100	%
	$_____	 	 	50	%

 

Whether or not the above conditions for acceleration are met, the
Committee may, but shall not be obligated to, in its sole discretion authorize full or partial acceleration of the Vesting Date
based upon its evaluation of the Company’s financial performance against such other performance measures as the Committee
may consider appropriate, including (by way of example and not limitation) cash flow, earnings, sales and margins.

 

(d)          Notwithstanding
paragraphs 2(a), 2(b) or 2(c), if there is a Change of Control before all shares of Company Stock have been issued to you under
this Award and either:

 

(i)           You
are and have been continuously employed by the Company or a Company Owned Entity through and on the effective date of the Change
of Control (the “CoC Effective Date”), or

 

(ii)          You
have been continuously employed by the Company or a Company Owned Entity and not more than ninety (90) days prior to the CoC Effective
Date your employment with the Company or Company Owned Entity is terminated, and such termination was done at the request of a
third party who, at such time, had taken steps reasonably calculated to effect a Change of Control, such termination was not because
of your death, Disability or for Cause, and such Change of Control subsequently does occur;

 

    	 	 	 

     

    

 

then the entire then-remaining undistributed portion of the Award
will be converted into the right to receive cash in an amount equal to the number of then-remaining PARS Units multiplied by the
average of the daily closing price of the Company’s common stock on the New York Stock Exchange over the last ten trading
days preceding the CoC Effective Date, and such cash will be paid to you (net of required tax withholdings) within 30 days after
the CoC Effective Date. However, in such event, the following additional terms will apply to the Award:

 

[Alternate A – For Awards
to Severance Plan Participants]

 

		(I)	Notwithstanding the foregoing provisions of this paragraph 2(d), in the event a certified public accounting firm designated
by the Committee (the “Accounting Firm”) determines that any payment (whether paid or payable pursuant to the terms
of this Award or otherwise and each such payment hereinafter defined as a “Payment” and all Payments in the aggregate
hereinafter defined as the “Aggregate Payment”), would subject you to tax under Section 4999 of the Internal Revenue
Code of 1986 (“Code”) then such Accounting Firm shall determine whether some amount of payments would meet the definition
of a “Reduced Amount”. If the Accounting Firm determines that there is a Reduced Amount, payments shall be reduced
so that the Aggregate Payments shall equal such Reduced Amount. For purposes of this clause 2(d)(I), the “Reduced Amount”
shall be the largest Aggregate Payment which (A) is less than the sum of all Payments and (B) results in aggregate Net After Tax
Receipts which are equal to or greater than the Net After Tax Receipts which would result if Payments were made without regard
to this clause 2(d)(I). “Net After Tax Receipt” means the Present Value (defined under Section 280G(d)(4) of the
Code) of a Payment net of all taxes imposed on you under Section 1 and 4999 of the Code by applying the highest marginal rate
under Section 1 of the Code.

 

[Alternate B – For Awards
to All Other Participants]

 

		(I)	Notwithstanding the foregoing provisions of this paragraph 2(d), in the event a certified public accounting firm designated
by the Committee (the “Accounting Firm”) determines that any payment (whether paid or payable pursuant to the terms
of this Award or otherwise and each such payment hereinafter defined as a “Payment” and all Payments in the aggregate
hereinafter defined as the “Aggregate Payment”), would subject you to tax under Section 4999 of the Internal Revenue
Code of 1986 (“Code”) then such Accounting Firm shall determine whether some amount of payments would meet the definition
of a “Reduced Amount”. If the Accounting Firm determines that there is a Reduced Amount, payments shall be reduced
so that the Aggregate Payments shall equal such Reduced Amount. For purposes of this clause 2(d)(I), the “Reduced Amount”
shall be the largest Aggregate Payment which results in no tax being imposed on the Participant under Section 4999 of the Code.

 

[Note: Include II for All Participants]

 

		(II)	As a result of the uncertainty in the application of Section 4999 of the Code at the time of the initial determination of the
Accounting Firm hereunder, it is possible that Payments will be made by the Company or a Company Owned Entity which should not
have been made (the “Overpayments”) or that additional Payments which the Company or a Company Owned Entity has not
made could have been made (the “Underpayments”), in each case consistent with the calculations of the Accounting Firm.
In the event that the Accounting Firm, based either upon (A) the assertion of a deficiency by the Internal Revenue Service against
the Company or a Company Owned Entity or you which the Accounting Firm believes has a high probability of success or (B) controlling
precedent or other substantial authority, determines that an Overpayment has been made, any such Overpayment shall be treated for
all purposes as a loan to you which you shall repay to the Company or Company Owned Entity together with interest at the applicable
Federal rate provided for in Section 7872(f)(2)(A) of the Code; provided, however, that no amount shall be payable by you to the
Company or Company Owned Entity if and to the extent such payment would not reduce the amount which is subject to taxation under
Section 1 and Section 4999 of the Code or if the period of limitations for assessment of tax has expired. In the event that the
Accounting Firm, based upon controlling precedent or other substantial authority, determines that an Underpayment has occurred,
any such Underpayment shall be promptly paid by the Company or Company Owned Entity to you together with interest at the applicable
Federal rate provided for in Section 7872(f)(2)(A) of the Code.

 

     

     

    

 

 

(e)          Notwithstanding
any other provision of this Section 2, if your employment terminates on account of death or Disability prior to the time you become
entitled to receive a distribution in respect of this Award, the Committee, in its absolute discretion, may make such full, pro-rata,
or no distribution of Company Stock in satisfaction of this Award as it may determine, either to you or, if termination is on
account of death, to your surviving spouse, heirs or estate as it may determine, all in its sole and complete discretion. If your
employment terminates on account of retirement with the approval of the Committee:

 

(i)          Any
PARS Award granted to you within 12 months prior to the participant’s retirement date shall be forfeited and no distribution
shall be made;

 

(ii)         With
respect to any other outstanding PARS Award, that portion, if any, of the Award for which the distribution date has been accelerated
in full or in part due to satisfaction of the applicable performance goal(s) prior to your retirement date shall vest and be distributed
in full;

 

(iii)        All
other outstanding PARS Awards (including any non-distributed portion of an Award distributed in part under the preceding clause
(ii)) shall vest and be distributed to you pro rata based on the number of months elapsed during the PARS Award Term as of the
retirement date compared to the total number of months in the PARS Award Term; and

 

(iv)        Any
distribution to which you become entitled under this section shall be made as soon as administratively feasible but not later than
21⁄2 months after your retirement date.

 

3. Share Ownership Requirements. You are expected
to own shares of Company Stock with a fair market value equal to a multiple of your total cash compensation (the “Share Ownership
Requirement”). If you do not currently meet your Share Ownership Requirement, you must retain 50% of any Award distribution
which you receive under Section 2 (which will be net of any tax withholdings) until the Share Ownership Requirement is satisfied.
Thereafter you must maintain ownership of a sufficient number of shares of Company Stock to ensure that the Share Ownership Requirement
remains satisfied. The satisfaction of the requirements of this Section 3 will be reviewed periodically as determined by the Committee.

 

4. Definitions. For purposes of the Award, the following
terms have the following meanings:

 

(a)          “30-Day
Average Value Per Share” means the average of the daily closing price of Company Stock on the New York Stock Exchange
over any period of 30 consecutive trading days on which Company Stock is traded.

 

(b)          “Cause”
means:

 

(i)           Your
willful and continued failure to perform substantially all of your duties with the Company or Company Owned Entity (other than
any such failure resulting from incapacity due to physical or mental illness), after a written demand for such performance is delivered
to you by the Company’s Board of Directors in a case where you are the Chief Executive Officer of the Company (“CEO”),
or otherwise by the CEO, which specifically identifies the manner in which such Board or CEO believes that you have not substantially
performed your duties, or

 

(ii)          Your
willful engagement in (A) illegal conduct (other than minor offenses), or (B) conduct which is in breach of your fiduciary
duty to the Company or Company Owned Entity and which is demonstrably injurious to the Company or Company Owned Entity, its reputation
or its business prospects.

 

(c)          “Change
of Control” means:

 

(i)          The
purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”) (excluding, for this purpose, the Company or its subsidiaries
or any employee benefit plan of the Company or its subsidiaries), of beneficial ownership (within the meaning of Rule 13d-3 promulgated
under the Exchange Act) of 20% or more of either the then-outstanding shares of common stock of the Company or the combined voting
power of the Company’s then-outstanding voting securities entitled to vote at any general or special meeting of shareholders;
or

 

     

     

    

 

(ii)          A change
in composition of the Board of Directors of the Company (the “Board” and, as of the date hereof, the “Incumbent
Board”) resulting in individuals who constitute the Incumbent Board ceasing for any reason to constitute at least a majority
of the Board, provided that any person who becomes a director subsequent to the date hereof whose election or nomination for election
by the Company’s shareholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent
Board (other than an individual whose initial assumption of office is in connection with an actual or threatened election contest
relating to the election of the directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated
under the Exchange Act) shall be, for purposes of this section, considered as though such person were a member of the Incumbent
Board; or

 

(iii)        Approval
by the stockholders of the Company of (A) a reorganization, merger or consolidation, in each case with respect to which persons
who were the stockholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately
thereafter, own more than 50% of, respectively, the common stock and the combined voting power entitled to vote generally in the
election of directors of the reorganized, merged or consolidated corporation’s then-outstanding voting securities, or (B)
a liquidation or dissolution of the Company or of the sale of all or substantially all of the assets of the Company.

 

Notwithstanding the foregoing, an isolated sale, spin-off, joint
venture or other business combination by the Company, which involves one or more divisions of the Company or Company Owned Entity
and is approved by a majority vote of the Incumbent Board, shall not be deemed to be a Change of Control.

 

(d)          “Company
Stock” means the common stock of the Company.

 

(e)          “Disability”
means your absence from your duties with the Company or Company Owned Entity on a full-time basis for 180 consecutive business
days as a result of incapacity due to mental or physical illness which incapacity is determined to be total and permanent by a
physician selected by the Company or Company Owned Entity or its insurers and acceptable to you or your legal representative.

 

(f)          “Fiscal
Year” means the fiscal year of the Company, which as of the date hereof is the twelve month period commencing October
1 and ending September 30.

 

[For UK Awards Only](g)“Personal
Data” means any personal information that could identify you.

 

5. Taxes. Company Stock issued pursuant to an Award
shall be valued for tax purposes at its closing price on the New York Stock Exchange on the Vesting Date, or if the Company Stock
is not traded on such Exchange on the Vesting Date, then on the last day prior to the Vesting Date on which the Company Stock is
traded on such Exchange. Sufficient shares of Company Stock or cash, as the case may be, shall be withheld from any distribution
hereunder to satisfy the Company’s tax withholding requirements in respect of such distribution.

 

[Alternate A – For Non-CA Awards Only]6. Covenants.

 

(a)          You
agree that during the period beginning on the Effective Date and ending two (2) years after the date on which you receive the final
distribution of Company Stock (or payment of cash, in the event of a Change of Control) to which you are or become entitled under
Section 2 of this Award, you will not do any of the following:

 

(i)           As
an individual or as a partner, employee, agent, advisor, consultant or in any other capacity of or to any person, firm, corporation
or other entity, directly or indirectly carry on any business or become involved in any business activity, which is (A) competitive
with the business of the Company or any Company Owned Entity, as presently conducted and as said business may evolve in the ordinary
course, and (B) a business or business activity in which you were engaged in the course of your employment with the Company or
any Company Owned Entity; but notwithstanding the foregoing, nothing herein shall prevent you from being a 2% or less shareholder
of a publicly traded corporation;

 

(ii)          As
an individual or as a partner, employee, agent, advisor, consultant or in any other capacity of or to any person, firm, corporation
or other entity, directly or indirectly recruit, solicit or hire, or assist anyone else in recruiting, soliciting or hiring, any
employee of the Company or any Company Owned Entity;

 

(iii)        Induce
or attempt to induce, or assist anyone else to induce or attempt to induce, any customer of the Company or any Company Owned Entity,
to discontinue its business with the Company or Company Owned Entity;

 

     

     

    

  

(iv)        Engage
in the unauthorized use or disclosure of confidential information or trade secrets of the Company or any Company Owned Entity resulting
in harm to the Company or any Company Owned Entity; or

 

(v)         Engage
in intentional misconduct resulting in a financial restatement or in an increase in your incentive or equity compensation.

 

(b)          In
the event of a breach or threatened breach of the covenants described in paragraph 6(a), the Company or any Company Owned Entity
shall be entitled, in addition to any other legal or equitable remedies it may have:

 

(i)           To
temporary, preliminary and permanent injunctive relief restraining such breach or threatened breach. You hereby expressly acknowledge
that the harm which might result as a result of any noncompliance by you would be largely irreparable, and you agree that if there
is a question as to the enforceability of any of the provisions of this Award, you will abide by the Award until after the question
has been resolved by a final judgment of a court of competent jurisdiction;

 

(ii)          To
cancel this Award; and/or

 

(iii)         To
recover from you (1) any shares of stock transferred to you under this Award during any period(s) (A) that you were in breach of
any of the above described covenants or (B) in the case of intentional misconduct resulting in a financial restatement during the
periods that required statement, but in either case not to exceed three years, and (2) the proceeds from any sales of such shares
received under this Award during the above time periods to the extent such shares transferred to you under this Award have been
sold or retained by the Company to pay your taxes. The Committee shall have sole discretion in determining the amount that shall
be recovered from you under this subparagraph 6(b)(iii).

 

[Alternate B – For CA Awards Only]6. Covenants.

 

(a)          To
the extent that you engage in conduct described in paragraph 6(b) during the period beginning on the Effective Date and ending
two (2) years after the date on which you receive the final distribution of Company Stock (or payment of cash, in the event of
a Change of Control) to which you are or become entitled under Section 2 of this Award, you agree that the Company or any Company
Owned Entity shall be entitled to recover amounts as described in paragraph 6(c).

 

(b)          The
conduct described in this paragraph 6(b) is any of the following:

 

(i)          As
an individual or as a partner, employee, agent, advisor, consultant or in any other capacity of or to any person, firm, corporation
or other entity, directly or indirectly carrying on any business or becoming involved in any business activity, which is (A) competitive
with the business of the Company or any Company Owned Entity, as presently conducted and as said business may evolve in the ordinary
course, and (B) a business or business activity in which you were engaged in the course of your employment with the Company or
any Company Owned Entity; but notwithstanding the foregoing, nothing herein shall prevent you from being a 2% or less shareholder
of a publicly traded corporation;

 

(ii)          As
an individual or as a partner, employee, agent, advisor, consultant or in any other capacity of or to any person, firm, corporation
or other entity, directly or indirectly recruiting, soliciting or hiring, or assisting anyone else in recruiting, soliciting or
hiring, any employee of the Company or any Company Owned Entity;

 

(iii)          Inducing
or attempting to induce, or assisting anyone else to induce or attempt to induce, any customer of the Company or any Company Owned
Entity, to discontinue its business with the Company or any Company Owned Entity;

 

(iv)          Engaging
in the unauthorized use or disclosure of confidential information or trade secrets of the Company or any Company Owned Entity resulting
in harm to the Company or any Company Owned Entity; or

 

(v)          Engaging
in intentional misconduct resulting in a financial restatement or in an increase in your incentive or equity compensation.

 

(c)          In
the event you engage in conduct described in paragraph 6(b), the Company or any Company Owned Entity shall be entitled:

 

(i)           To
cancel this Award; and/or

 

    	 	 	 

     

    

 

(ii)          To
recover from you (1) any shares of stock transferred to you under this Award during any period(s) (A) that you were in breach of
any of the above described covenants or (B) in the case of intentional misconduct resulting in a financial restatement during the
periods that required statement, but in either case not to exceed three years , and (2) the proceeds from any sales of such shares
received under this Award during the above time periods to the extent such shares transferred to you under this Award have been
sold or retained by the Company to pay your taxes. The Committee shall have sole discretion in determining the amount that shall
be recovered from you under this subparagraph (ii).

 

7. Choice of Law; Venue. This Award shall be construed
and administered in accordance with the laws of the State of Missouri without regard to the principles of conflicts of law which
might otherwise apply. In light of the fact that the Company is headquartered in St. Louis, Missouri, the Plan was established
and is administered in the State of Missouri and the majority of the Committee’s meetings are held in the State of Missouri,
any litigation concerning any aspect of this Award shall be conducted exclusively in the State or Federal Courts in the State of
Missouri.

 

8. Severability. Whenever possible, each provision
of this Agreement will be interpreted in such manner as to be effective and valid under applicable law. If any provision of this
Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction,
(a) the parties agree that such provision(s) will be enforced to the maximum extent permissible under the applicable law, and (b)
any invalidity, illegality or unenforceability of a particular provision will not affect any other provision of this Agreement.

 

9. Amendment. The Award may be amended by written
consent between the Company and you.

 

[For UK Awards Only]10. Data Protection.

 

(a)          In
accepting the grant of the PARS Unit(s), you consent to the collection, holding, processing and transfer of your Personal Data
by the Company or any Company Owned Entity for all purposes connected with the operation of the Plan.

 

(b)          The
purposes of the Plan referred to in paragraph 10(a) include, but are not limited to:

 

(i)           Holding
and maintaining details of your PARS Units;

 

(ii)          Transferring
your Personal Data to the trustee of an employee benefit trust, the Company’s registrars or brokers or any administrators
of the Plan;

 

(iii)         Transferring
your Personal Data to a bona fide prospective buyer of the Company or any Company Owned Entity or business unit (or the prospective
buyer’s advisers), provided that the prospective buyer, and its advisers, irrevocably agree to use your Personal Data only
in connection with the proposed transaction and in accordance with the data protection principles set out in the Data Protection
Act 1998; and

 

(iv)          Transferring
your Personal Data under paragraph 10(b)(ii) or paragraph 10(b)(iii) to a person who is resident in a country or territory outside
UK or the European Economic Area that may not provide the same statutory protection for the information as countries within the
European Economic Area.

 

[For Awards to Licensed Attorneys Only]11. Ethical
Obligations. In recognition of your ethical duties and responsibilities as a licensed attorney, the parties agree that
nothing in this Award shall prevent you from providing legal advice or otherwise being engaged in the practice of law; provided,
however, that you agree not to breach any ethical obligations you have by virtue of being, or having been, the Company’s
corporate counsel.

 

	Executed __________, 20__.	 	 
	 	 	 
	ESCO TECHNOLOGIES INC.	 	AGREED TO AND ACCEPTED:

	 	 	 	 
	By:	 	 	 

	Vice President	 	Participant

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]